Aptamer, York life sciences firm, signs new deal

York-based life sciences firm Aptamer Group plc has announced that following initial positive results from a project with “a multi-national consumer goods company” it has signed a follow on deal to develop Optimer binders as novel solutions for a direct-to-consumer personal care product.

“The deal could be worth up to £185,000, subject to the successful progression of Optimer development, and is the latest in a series of new contracts that demonstrates strong momentum in the first weeks of the second half of the year,” said Aptamer.

“Today’s deal builds on announced work to date including £1.0m in signed orders and £1.0m of recognised H1 revenue announced in a recent trading update, as well as £500,000 from two fee-for-service contracts, announced last week.”

Aptamer Group CEO Arron Tolley said: “It’s been a busy January at Aptamer, and this latest deal reflects the momentum within the business and the demand for our aptamer solutions.

“We’re pleased to continue our work with this multi-national consumer goods company on this interesting personal care application, further validating our technology and our leadership position in developing novel aptamers.

“This deal also showcases the wider applicability of our technology and that Optimer binders can support improved solutions within the cosmetic development space. I look forward to reporting further progress on this highly exciting project.”